Testosterone Science

Alternatives to Testosterone Therapy

Is Enclomiphene FDA-Approved?

Specific Claim Evaluated

Unlike testosterone therapy, enclomiphene does not suppress sperm production and may even help preserve or improve fertility.

Primary Research Supporting or Contradicting the Claim

In phase 3 trials, enclomiphene maintained sperm concentration in the normal range over 16 weeks while testosterone gel reduced it; no fertility or pregnancy outcomes were measured (Kim et al., 2016).

Corrected Evidence-Based Interpretation

Enclomiphene preserves sperm concentration over months in men with secondary hypogonadism, but there is no evidence that it improves fertility outcomes, and it is not FDA approved.

Rationale for Grade

The page states the regulatory history accurately but presents preservation of a semen parameter as preservation or improvement of fertility. This extends the trial end point to a clinical outcome that was not studied, and the publisher sells the product.

References

  1. Kim ED, McCullough A, Kaminetsky J. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU Int. 2016;117(4):677-685. PMID
    Supporting excerpt: "Enclomiphene citrate treatment maintained sperm concentrations in the normal range."

Post a Comment

Shared Decision Making

Bring the Evidence to Your Next Consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.